Patent Law Weblog
recent posts
- Moderna Settles Patent Litigation with Arbutus et al.
- USPTO and DOJ Statement of Interest in Collision Communications: Another Thumb on the Scale in Favor of NPE Patent Plaintiffs
- Oasis Tooling, Inc. v. Siemens Industry Software Inc. (Fed. Cir. 2026)
- Why AI Will Not Take Over the World
- BioNTech Sues Moderna over mRNA Vaccine Technology
about
Category: Media Commentary
-
By Kevin E. Noonan — Published articles in the popular press rarely report accurately about patents and the patent system. That's why it is unexpected, remarkable, and incredibly timely that the Milwaukee Journal Sentinel published not one but two in-depth articles about patents and the U.S. Patent and Trademark Office this week. Written by…
-
By Kevin E. Noonan — As reported today in a Patent Docs post, Economist Alex Brill (at right) has proposed that Congress include in patent reform legislation provisions "putting some teeth" into the penalties available for inequitable conduct, presumably as a way to discourage it. These "teeth" include "criminal penalties, punitive damages and jail…
-
By Donald Zuhn — Economist Alex Brill, who last fall released a report on follow-on biologics, is back, this time focusing on proposals for "reforming" the U.S. patent system instead of suggestions for creating a follow-on biologics regulatory pathway. Patent Docs readers may recall that in November, Mr. Brill (at right), a research fellow…
-
By Kevin E. Noonan — Like a broken clock that nonetheless tells the right time twice a day, it was inevitable that The New York Times would eventually run a story where they got it right on patenting (see "Crop Scientists Say Biotechnology Seed Companies Are Thwarting Research"). It was, of course, a story…
-
By Kevin E. Noonan — Congress has the power, under Article I of the U.S. Constitution, to grant patents "to promote the progress of Science and the Useful Arts." The value of patenting to the public is disclosure –- the raw material that drives progress is full disclosure of an invention in a patent…
-
By Kevin E. Noonan — Perhaps the most beautiful sentence in scientific literature is this one: It has not escaped our notice that the specific pairing we have postulated immediately suggests a possible copying mechanism for the genetic material. James Watson & Francis Crick, "Molecular Structure of Nucleic Acids; A Structure for Deoxyribose Nucleic…
-
By Kevin E. Noonan — Ah, the popular press! Purported protectors of our fundamental freedoms, their behavior (at least in the mainstream press) has recently been less than noble. Eschewing the role of crusader (or even muckraker), the press seems to look for the common popular denominator of received wisdom, and then to trumpet…
-
By Kevin E. Noonan — The New York Times seems to have an unending supply of pundits willing to support its anti-patent agenda, as has been noted on this blog before (see below). The latest example is an article in this Saturday’s paper, entitled "When Academia Puts Profit Ahead of Wonder," by Janet…
-
Last week, Patent Docs posted an article by Kevin Noonan (see "Once Again, The New Yorker Gets It Wrong on Patents") regarding "The Permission Problem," an article by James Surowiecki that appears in the August 11th edition of The New Yorker. Over the weekend, Mr. Surowiecki and Dr. Noonan engaged in an interesting and spirited…
-
By Kevin E. Noonan — James Surowiecki is exercising his antipatent animus once again in the August 11th edition of The New Yorker. Mr. Surowiecki (at right) writes a weekly column called "The Financial Page" in the magazine, and he has shown that he doesn’t like patents several times in his work. These…
Patent Docs 